M
Michelle L. de Oliveira
Researcher at University of Zurich
Publications - 20
Citations - 8531
Michelle L. de Oliveira is an academic researcher from University of Zurich. The author has contributed to research in topics: Liver transplantation & Medicine. The author has an hindex of 10, co-authored 17 publications receiving 6238 citations.
Papers
More filters
Journal ArticleDOI
Modern therapeutic approaches for the treatment of malignant liver tumours
Henrik Petrowsky,Ralph Fritsch,Matthias Guckenberger,Michelle L. de Oliveira,Philipp Dutkowski,Pierre-Alain Clavien +5 more
TL;DR: The available therapies for the treatment of malignant liver tumours are summarized, with an emphasis on surgical and ablative approaches and how they align with other therapies such as modern anticancer drugs or radiotherapy.
Journal ArticleDOI
Perihilar Cholangiocarcinoma - Novel Benchmark Values for Surgical and Oncological Outcomes From 24 Expert Centers.
Matteo Mueller,Eva Breuer,Takashi Mizuno,Fabian Bartsch,Francesca Ratti,Christian Benzing,Noémie Ammar-Khodja,Teiichi Sugiura,Tsukasa Takayashiki,Amelia J. Hessheimer,Hyung Sun Kim,Andrea Ruzzenente,Keun Soo Ahn,Tiffany C.L. Wong,Jan Bednarsch,Mizelle D'Silva,Bas Groot Koerkamp,Heithem Jeddou,Victor Lopez-Lopez,Charles de Ponthaud,Jennifer A. Yonkus,Warsan Ismail,Lynn E Nooijen,Camila Hidalgo-Salinas,Elissaios Kontis,Kim C Wagner,Ganesh Gunasekaran,Ryota Higuchi,Ana Gleisner,Chaya Shwaartz,Gonzalo Sapisochin,Richard D. Schulick,Masakazu Yamamoto,Takehiro Noji,Satoshi Hirano,Myron Schwartz,Karl J. Oldhafer,Andreas Prachalias,Giuseppe Fusai,Joris I. Erdmann,Pål-Dag Line,Rory L. Smoot,Olivier Soubrane,Ricardo Robles-Campos,Karim Boudjema,Wojciech G. Polak,Ho-Seong Han,Ulf P. Neumann,Chung Mau Lo,Koo Jeong Kang,Alfredo Guglielmi,Joon Seong Park,Constantino Fondevila,Masayuki Ohtsuka,Katsuhiko Uesaka,René Adam,Johann Pratschke,Luca Aldrighetti,Michelle L. de Oliveira,Gregory J. Gores,Hauke Lang,Masato Nagino,Pierre-Alain Clavien +62 more
TL;DR: In this article, the authors defined robust benchmark values for the surgical treatment of perihilar cholangiocarcinomas (PHC) to enable unbiased comparisons and analyzed consecutive patients undergoing major liver surgery for PHC in 24 highvolume centers in 3 continents over the recent 5-year period (2014-2018) with a minimum follow-up of 1 year in each patient.
Journal ArticleDOI
Is single portal vein approach sufficient for hypothermic machine perfusion of DCD liver grafts
TL;DR: Variable Median (IQR) or frequency (%) Donor age (years) 58 (40-66) No.
Journal ArticleDOI
Can immunosuppression be stopped after liver transplantation
Pierre-Alain Clavien,Xavier Muller,Michelle L. de Oliveira,Philipp Dutkowski,Alberto Sanchez-Fueyo +4 more
TL;DR: The current understanding of liver-specific immune responses is summarized, and strategies for complete drug withdrawal should be selected carefully to avoid graft rejection.
Journal ArticleDOI
Hepatic artery occlusion in liver transplantation: What counts more, the type of reconstruction or the severity of the recipient's disease?
Christian E. Oberkofler,Tim Reese,Dimitri A. Raptis,Christoph Kuemmerli,Olivier de Rougemont,Michelle L. de Oliveira,Andrea Schlegel,Philipp Dutkowski,Pierre-Alain Clavien,Henrik Petrowsky +9 more
TL;DR: In this paper, a multivariate model was used to identify independent risk factors for occlusion and the need of arterial conduit, as well as their impact on graft and patient survival.